MADRIGAL PHARMACEUTICALS, INC. (MDGL) Net income 2017–2025
MADRIGAL PHARMACEUTICALS, INC. (MDGL) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$288.3MFY2025 · since FY2017: -$31.2M → -$288.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$288.3M | +38.1% |
| FY2024 | -$465.9M | -24.7% |
| FY2023 | -$373.6M | -26.5% |
| FY2022 | -$295.4M | -22.1% |
| FY2021 | -$241.8M | -19.6% |
| FY2020 | -$202.2M | -140.9% |
| FY2019 | -$83.9M | -155.9% |
| FY2018 | -$32.8M | -5.3% |
| FY2017 | -$31.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice